Scientists have reached a major milestone in animal-to-human transplant research as the U.S. Food and Drug Administration has approved the first human clinical trials for kidney transplants from genetically modified pigs.

According to biotech company eGenesis, the FDA has given a green light to its Investigational New Drug (IND) application to initiate a clinical trial evaluating its genetically engineered kidneys, referred to as EGEN-2784, in patients with end-stage kidney disease.

The approval marks a significant step forward in addressing the critical organ shortage facing thousands of Americans.

There are over 100,000 Americans on organ transplant waiting lists, with kidneys representing the most needed organ type. Current wait times for kidney transplants can extend several years,

See Full Page